Sort
261,768 grants matching “gene therapy”
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles
$1,638,192Zheng-Yi Chen · Massachusetts Eye And Ear Infirmary · UH3 · FY2021 · TR
Overcoming BRAF-inhibitor Resistance in Melanoma
$1,638,184Antoni Ribas · University Of California Los Angeles · P01 · FY2014 · CA
Mechanisms of Esophageal Carcinogenesis
$1,638,087Anil K Rustgi · Columbia University Health Sciences · P01 · FY2019 · CA
Mechanisms of Esophageal Carcinogenesis
$1,637,533Anil K Rustgi · University Of Pennsylvania · P01 · FY2014 · CA
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
$1,637,497Marc Nathan Wein · Massachusetts General Hospital · P50 · FY2024 · AR
Molecular Atlas of Lung Development - Data Coordinating Center
$1,637,477Scott M Palmer · Duke University · U01 · FY2016 · HL
GENE THERAPY FOR CYSTIC FIBROSIS
$1,637,455University Of North Carolina Chapel Hill · P01 · FY2001 · HL
ER Stress and Mitochondrial Biogenesis in Melanoma
$1,637,236Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2019 · CA
Prostate Cancer Bone Metastasis Biology and Targeting
$1,637,216Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2017 · CA
Mitochondrial Dysfunction in Neurodegeneration of Aging
$1,636,811Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2010 · AG
Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC
$1,636,777Mary Beth Terry · Columbia University Health Sciences · R01 · FY2014 · CA
Comprehensive NeuroAIDS Center
$1,636,611Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2017 · MH
A New and Disruptive Gene Based Therapy for Atrial Fibrillation
$1,636,504Robert Charles Moen · Inomagen Therapeutics, Inc · R44 · FY2022 · HL
Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery
$1,636,379Kirk Seward · Mercator Medsystems, Inc. · R44 · FY2024 · HL
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,636,238Walther H Mothes · Utah State Higher Education System--University Of Utah · U54 · FY2025 · AI
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,636,160Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
$1,636,073Akiko Shimamura · Boston Children'S Hospital · R24 · FY2016 · DK
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
$1,636,056Akiko Shimamura · Boston Children'S Hospital · R24 · FY2017 · DK
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy
$1,636,040Daniel Rotroff · Cleveland Clinic Lerner Com-Cwru · R33 · FY2023 · NS
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,635,928Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Neurotology program
$1,635,865Wade Chien · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,635,674Michael B Oldstone · Scripps Research Institute, The · U01 · FY2011 · AI
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
$1,635,660Akiko Shimamura · Boston Children'S Hospital · R24 · FY2015 · DK
Phase II Trial of Lonafarnib, Pravastatin and Zoledronic Acid in Progeria
$1,635,620Mark W Kieran · Dana-Farber Cancer Inst · RC2 · FY2010 · HL
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
$1,635,392Akiko Shimamura · Fred Hutchinson Cancer Research Center · R24 · FY2014 · DK